Kazimierz Halaburda
0000-0003-3624-785X
Institute of Hematology and Transfusion Medicine
147 papers found
Refreshing results…
Extrapulmonary tuberculosis following allogeneic stem cell transplantation - A difficult and late diagnosis
Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia
2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland
Clinical evaluation of busulfan, cladribine and alemtuzumab as reduced intensity conditioning for stem cell transplantation
Extramedullary relapse of acute myelogenous leukaemia due to chronic GVHD as a complication of allogeneic HSCT
Extrapulmonary manifestation of tuberculosis in allogeneic stem cell transplant recipients
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant
The significance of palifermin in reduction of oral mucositis incidence and acute graft-versus-host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant
Palifermin (Kepivance) in prevention of oral mucositis in patients with haematological diseases undergoing allogeneic stem cell transplantation
Limited predictive value of real-time quantitative PCR cytomegalovirus monitoring in the blood. Fatal CMV pneumonia in an autologous stem cell transplant recipient previously treated with alemtuzumab
Expression of cytokine receptors on CD34+bone marrow cells 100 days after autologous stem cell transplantation
The significance of palifermin (Kepivance (R)) in reduction of oral mucositis (OM) incidence and acute graft versus host disease in patients with hematologic malignancies under-going hematopoietic stem cell transplantation (HSCT)
The Significance of Palifermin (Kepivance) in Reduction of Oral Mucositis (OM) Incidence and Acute Graft Versus Host Disease (aGvHD) in Patients with Hematological Diseases Undergoing HSCT.
Allogeneic bone marrow transplantation for hypereosinophilic syndrome: Long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript
Real-time PCR for early chimerism evaluation in peripheral blood mononuclear cells of allogeneic stem cell recipients: potential value for prediction of acute graft-versus-host disease
Guillain-Barre syndrome--pathological connection with GvHD after allogeneic bone marrow transplantation.
Extramedullary relapse of APL in the pleura, heart and pericardium after allogeneic BMT
Allogeneic bone marrow transplantation for hypereosinophilic syndrome: Long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript [5]
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease
Clinical impact of early complete donor chimerism after allogeneic stem cell transplantation
Missing publications? Search for publications with a matching author name.